Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report

被引:0
作者
Elisabetta Fenocchio
Ilaria Depetris
Delia Campanella
Lucia Garetto
Fabrizio Carnevale Schianca
Danilo Galizia
Giovanni Grignani
Massimo Aglietta
Francesco Leone
机构
[1] University of Turin Medical School,Department of Medical Oncology
[2] Candiolo Cancer Institute,Radiology Department
[3] FPO,undefined
[4] IRCCS,undefined
[5] Candiolo Cancer Institute,undefined
[6] FPO,undefined
[7] IRCCS,undefined
来源
BMC Cancer | / 16卷
关键词
Gemcitabine; Pancreatic cancer; Pulmonary toxicity; Imatinib mesylate; Treatment outcome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 115 条
[1]  
Siegel R(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
[2]  
Ma J(2013)Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JAMA 310 1473-81
[3]  
Zou Z(2002)Gemcitabine-induced pulmonary toxicity: case report and review of the literature Am J Clin Oncol 25 96-100
[4]  
Jemal A(2011)Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin’s lymphoma: hope for severe chemotherapy-induced toxicity? J Clin Oncol 29 e691-3
[5]  
Oettle H(2004)Gemcitabine-induced severe pulmonary toxicity Fundam Clin Pharmacol 18 85-91
[6]  
Neuhaus P(2011)Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer J Cancer Res Clin Oncol 137 1469-75
[7]  
Hochhaus A(2008)Pulmonary complications of novel antineoplastic agents for solid tumors Chest 133 528-38
[8]  
Hartmann JT(2002)A report on serious pulmonary toxicity associated with gemcitabine-based therapy Invest New Drugs 20 311-5
[9]  
Gellert K(2006)Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project Cancer 106 2051-7
[10]  
Ridwelski K(2010)Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer JOP 11 186-8